The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.
Open Access
- 1 February 1970
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 33 (1), 1-6
- https://doi.org/10.1136/jnnp.33.1.1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effects of L-Dopa in Parkinson??s DiseaseJournal of Occupational and Environmental Medicine, 1970
- EFFECTS OF L-DOPA IN PARKINSON'S DISEASEThe Lancet, 1969
- L-DOPA IN POSTENCEPHALITIC PARKINSONISMThe Lancet, 1969
- Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's DiseaseNature, 1968
- Acceleration of the cerebral dopamine turnover by chlorpromazineCellular and Molecular Life Sciences, 1966
- Herabgesetzte Konzentration der Homovanillinsäure im Gehirn von parkinsonkranken Menschen als Ausdruck der Störung des zentralen DopaminstoffwechselsKlinische Wochenschrift, 1965
- Demonstration and mapping out of nigro-neostriatal dopamine neuronsLife Sciences, 1964
- On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric methodLife Sciences, 1963
- CHEMICAL AND PHYSIOLOGICAL CHANGES PRODUCED BY ARTERIAL INFUSION OF DIHYDROXY‐PHENYLALANINE INTO ONE CEREBRAL HEMISPHERE OF THE CATJournal of Neurochemistry, 1963
- MICROANALYTICAL PROCEDURES FOR FLUORO‐METRIC ASSAY OF BRAIN DOPA‐5HTP DECARBOXYLASE, NOREPINEPHRINE AND SEROTONIN, AND A DETAILED MAPPING OF DECARBOXYLASE ACTIVITY IN BRAINJournal of Neurochemistry, 1961